Jessica Cohen

Jessica Cohen is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Director and Core Team Lead for Palynziq at BioMarin Pharmaceutical Inc. since February 2012. Prior roles at BioMarin include Executive Medical Director overseeing clinical development for late-stage enzyme replacement therapy with intrathecal delivery, acting as Medical Monitor for an HAE gene therapy trial, and leading Medical Affairs in North America. Prior to BioMarin, Jessica held academic positions at Mount Sinai Medical Center as both an Adjunct Assistant Professor and Assistant Professor in Genetics and Genomic Sciences. Jessica holds a Medical Geneticist degree from the Icahn School of Medicine at Mount Sinai, a Pediatric Residency from Miami Children's Hospital, and a Medico Cirujano (MD) degree from Universidad Central de Venezuela.